H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)

June 11, 2026 6:43 AM

H.C. Wainwright analyst Andrew S. Fein reiterated a Buy rating and $13.00 price target on WAVE Life Sciences (NASDAQ: WVE).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found